stella
beta
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy — Stella
Home
/
Spinal Muscular Atrophy
/
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
View on ClinicalTrials.gov
Recruiting
Back to Spinal Muscular Atrophy trials
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(23 sites)
United States
Phoenix Children's Hospital, Phoenix, Arizona
Children's Hospital of Orange County (CHOC), Orange, California
Stanford Neuroscience Health Center (SNHC), Palo Alto, California
Children's Hospital Colorado, Aurora, Colorado
University of Iowa, Iowa City, Iowa
Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan
Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina
The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
Le Bonheur Children's Hospital, Memphis, Tennessee
University of Texas Southwestern Medical Center, Dallas, Texas
Neurology Rare Disease Center, Flower Mound, Texas
Cook Children's Medical Center, Fort Worth, Texas
Texas Children's Hospital (TCH)-Clinical Care Center (CCC), Houston, Texas
Belgium
UZ Gent, Ghent, East-Flanders
UZ Leuven - Campus Gasthuisberg, Leuven
CHR Citadelle, Liège
France
Hopital Trousseau - I-Motion, Paris
Italy
Fondazione I.R.C.C.S. - Istituto Neurologico Carlo Besta, Milan
Centro Clinico NeMO Milano - Fondazione Serena Onlus, Milan
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome
Netherlands
Universitair Medisch Centrum Utrecht, Utrecht
Spain
Hospital Sant Joan de Déu Barcelona, Barcelona
Hospital Universitari i Politecnico La Fecnic La Fe, Valencia